These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 29571430)

  • 1. No-HDL-cholesterol as risk marker and therapeutic goal.
    Millán Núnez-Cortés J
    Clin Investig Arterioscler; 2018; 30(2):72-73. PubMed ID: 29571430
    [No Abstract]   [Full Text] [Related]  

  • 2. Up with HDL, the "good" cholesterol. Guidelines mainly target LDL cholesterol, but HDL matters, too.
    Harv Womens Health Watch; 2008 Jun; 15(10):2-3. PubMed ID: 18853517
    [No Abstract]   [Full Text] [Related]  

  • 3. [Lower LDL and/or raise HDL. In what direction is lipidology moving?].
    Parhofer KG
    MMW Fortschr Med; 2007 May; 149(22):27. PubMed ID: 18069222
    [No Abstract]   [Full Text] [Related]  

  • 4. High blood cholesterol.
    National Heart, Lung and Blood Institute
    Nutr Clin Care; 2003; 6(3):108-14. PubMed ID: 14979453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Atherosclerosis and hypercholesterolemia in pediatric and adolescent medicine].
    Ratzmann GW
    Arztl Jugendkd; 1991; 82(1):41-3. PubMed ID: 1927728
    [No Abstract]   [Full Text] [Related]  

  • 6. [High cholesterol level may protect against infections and probably also atherosclerosis].
    Ravnskov U
    Lakartidningen; 2004 Mar; 101(13):1215-7; discussion 1218, 1221-2. PubMed ID: 15101249
    [No Abstract]   [Full Text] [Related]  

  • 7. What role does HDL cholesterol have in CVD and what is the most effective way to increase it?
    Marcason W
    J Am Diet Assoc; 2011 Aug; 111(8):1266. PubMed ID: 21802575
    [No Abstract]   [Full Text] [Related]  

  • 8. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
    Cziraky MJ; Watson KE; Talbert RL
    J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Can higher level of HDL cholesterol augment cardiovascular disease prevention? The combination statins-nicotinic acid increases the level of HDL and reduces the level of LDL cholesterol].
    Carlson LA
    Lakartidningen; 2006 Oct 25-31; 103(43):3283-5. PubMed ID: 17117660
    [No Abstract]   [Full Text] [Related]  

  • 10. LDL-cholesterol lowering or HDL-cholesterol raising for cardiovascular prevention. A lesson from cholesterol turnover studies and others.
    Sirtori CR; Fumagalli R
    Atherosclerosis; 2006 May; 186(1):1-11. PubMed ID: 16310198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hypercholesteremia].
    Leiss O
    Dtsch Med Wochenschr; 2001 Jun; 126(23):704-5. PubMed ID: 11441669
    [No Abstract]   [Full Text] [Related]  

  • 12. [What is a good marker for serum cholesterol to identify high-risk patients at general health checks?].
    Fujioka Y
    Rinsho Byori; 2012 Apr; 60(4):328-35. PubMed ID: 22686042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity, ultrasound indexes of fat depots and lipid goal attainment in patients with high and very high cardiovascular risk: A novel approach towards better risk reduction.
    Haberka M; Okopień B; Gąsior Z
    Nutr Metab Cardiovasc Dis; 2016 Feb; 26(2):123-33. PubMed ID: 26830392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-reactive protein and cholesterol are equally strong predictors of cardiovascular risk and both are important for quality clinical care.
    Ridker PM; Kastelein JJ; Genest J; Koenig W
    Eur Heart J; 2013 May; 34(17):1258-61. PubMed ID: 23376447
    [No Abstract]   [Full Text] [Related]  

  • 15. LDL-C/HDL-C ratio in subjects with cardiovascular disease and a low HDL-C: results of the RADAR (Rosuvastatin and Atorvastatin in different Dosages And Reverse cholesterol transport) study.
    Jukema JW; Liem AH; Dunselman PH; van der Sloot JA; Lok DJ; Zwinderman AH
    Curr Med Res Opin; 2005 Nov; 21(11):1865-74. PubMed ID: 16307708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency of Attainment of Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol Goals in Cardiovascular Clinical Practice (from the National Cardiovascular Data Registry PINNACLE Registry).
    Spinler SA; Cziraky MJ; Willey VJ; Tang F; Maddox TM; Thomas T; Dueñas GG; Virani SS;
    Am J Cardiol; 2015 Aug; 116(4):547-53. PubMed ID: 26089010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is high-density lipoprotein cardioprotective or simply a marker of cardiovascular disease?
    Mooradian AD
    Am J Ther; 2014; 21(5):438-9. PubMed ID: 23528372
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of non-HDL cholesterol as a predictor of non-fatal cardiovascular events in a prospective population cohort.
    Carbayo Herencia JA; Simarro Rueda M; Palazón Bru A; Molina Escribano F; Ponce García I; Artigao Ródenas LM; Caldevilla Bernardo D; Divisón Garrote JA; Gil Guillén VF;
    Clin Investig Arterioscler; 2018; 30(2):64-71. PubMed ID: 29395492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary results of HDL levels in the Düzce region (Turkey): normal rather than low.
    Yüksel HK; Coşkun A; Duran S; Yavuz O
    Anadolu Kardiyol Derg; 2006 Jun; 6(2):174-5. PubMed ID: 16766284
    [No Abstract]   [Full Text] [Related]  

  • 20. Residual dyslipidemia according to low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B among statin-treated US adults: National Health and Nutrition Examination Survey 2009-2010.
    Wong ND; Chuang J; Zhao Y; Rosenblit PD
    J Clin Lipidol; 2015; 9(4):525-32. PubMed ID: 26228670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.